Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?

Denali Therapeutics Inc. (DNLI) shares ended the last trading session 9.7% higher at $23.53. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 5.2% loss over the past four weeks. The FDA recently selected its experimental candidate, DNL126, in support of clinical trials advancing the rare disease therapeutics Pilot Program. The pipeline progress has been encouraging as well. Earnings and revenue growth expectations c ...